Trial no.:
|
PACTR201805003241310 |
Date of Approval:
|
22/03/2018 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Transversus Abdominus Plane (TAP) Block for Postoperative Analgesia After Day-Case Inguinal Hernia Repair in a Ghanaian Tertiary Hospital |
Official scientific title |
Transversus Abdominus Plane (TAP) Block for Postoperative Analgesia After Day-Case Inguinal Hernia Repair in a Ghanaian Tertiary Hospital |
Brief summary describing the background
and objectives of the trial
|
Background
Inguinal hernia is a common condition whose only effective management is surgical repair. Hernia repair may be performed as an open or laparoscopic procedure and is associated with significant postoperative pain especially with open procedures. The severity of acute postoperative pain has been identified as a major predictive factor for the development of chronic pain syndromes such as chronic post-herniorrhaphy inguinal pain (CPIP). Multimodal analgesia involving techniques such as the transversus abdominis plane (TAP) block are increasingly being employed for the effective management of acute postoperative pain.
OBJECTIVES
1. To compare the mean NRS scores in patients in the intervention group versus those the control group.
2. To compare the time to first analgesia in patients in the intervention group versus those in the control group.
3. To compare the degree of patient satisfaction with pain relief within the first 24 hours postoperatively in the intervention group versus control group.
4. To compare the incidence of postoperative nausea and vomiting in the intervention group versus control group.
5. To compare the total amount of opioid analgesia consumed in patients in the intervention group versus those in the control group.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Digestive System,INGUINAL HERNIA,Surgery |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Drugs |
Anticipated trial start date |
02/04/2018 |
Actual trial start date |
02/01/2019 |
Anticipated date of last follow up |
29/08/2019 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
60 |
Actual target sample size (number of participants) |
|
Recruitment status |
Recruiting |
Publication URL |
|
|